Applied Technology Genetics (ATGC) gets grant for Rhesus incompatibility test
This article was originally published in Clinica
Executive Summary
Applied Technology Genetics plans to develop a new, DNA-based diagnostic test for maternal-foetal rhesus (Rh) blood group incompatibility, thanks to a two-year $630,000 grant from the US National Institutes of Health. The development of an accurate, direct method for assessing foetal risk for maternal foetal Rh incompatibility would obviate the need for current risky and costly invasive procedures, such as serial amniocenteses or percutaneous umbilical cord sampling.